Cargando…

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity

The mechanisms for maintaining oral cavity homeostasis are subject to the constant influence of many environmental factors, including various chemicals and microorganisms. Most of them act directly on the oral mucosa, which is the mechanical and immune barrier of the oral cavity, and such interactio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokajuk, Joanna, Deptuła, Piotr, Piktel, Ewelina, Daniluk, Tamara, Chmielewska, Sylwia, Wollny, Tomasz, Wolak, Przemysław, Fiedoruk, Krzysztof, Bucki, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138798/
https://www.ncbi.nlm.nih.gov/pubmed/35625823
http://dx.doi.org/10.3390/biomedicines10051086
_version_ 1784714708435075072
author Tokajuk, Joanna
Deptuła, Piotr
Piktel, Ewelina
Daniluk, Tamara
Chmielewska, Sylwia
Wollny, Tomasz
Wolak, Przemysław
Fiedoruk, Krzysztof
Bucki, Robert
author_facet Tokajuk, Joanna
Deptuła, Piotr
Piktel, Ewelina
Daniluk, Tamara
Chmielewska, Sylwia
Wollny, Tomasz
Wolak, Przemysław
Fiedoruk, Krzysztof
Bucki, Robert
author_sort Tokajuk, Joanna
collection PubMed
description The mechanisms for maintaining oral cavity homeostasis are subject to the constant influence of many environmental factors, including various chemicals and microorganisms. Most of them act directly on the oral mucosa, which is the mechanical and immune barrier of the oral cavity, and such interaction might lead to the development of various oral pathologies and systemic diseases. Two important players in maintaining oral health or developing oral pathology are the oral microbiota and various immune molecules that are involved in controlling its quantitative and qualitative composition. The LL-37 peptide is an important molecule that upon release from human cathelicidin (hCAP-18) can directly perform antimicrobial action after insertion into surface structures of microorganisms and immunomodulatory function as an agonist of different cell membrane receptors. Oral LL-37 expression is an important factor in oral homeostasis that maintains the physiological microbiota but is also involved in the development of oral dysbiosis, infectious diseases (including viral, bacterial, and fungal infections), autoimmune diseases, and oral carcinomas. This peptide has also been proposed as a marker of inflammation severity and treatment outcome.
format Online
Article
Text
id pubmed-9138798
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91387982022-05-28 Cathelicidin LL-37 in Health and Diseases of the Oral Cavity Tokajuk, Joanna Deptuła, Piotr Piktel, Ewelina Daniluk, Tamara Chmielewska, Sylwia Wollny, Tomasz Wolak, Przemysław Fiedoruk, Krzysztof Bucki, Robert Biomedicines Review The mechanisms for maintaining oral cavity homeostasis are subject to the constant influence of many environmental factors, including various chemicals and microorganisms. Most of them act directly on the oral mucosa, which is the mechanical and immune barrier of the oral cavity, and such interaction might lead to the development of various oral pathologies and systemic diseases. Two important players in maintaining oral health or developing oral pathology are the oral microbiota and various immune molecules that are involved in controlling its quantitative and qualitative composition. The LL-37 peptide is an important molecule that upon release from human cathelicidin (hCAP-18) can directly perform antimicrobial action after insertion into surface structures of microorganisms and immunomodulatory function as an agonist of different cell membrane receptors. Oral LL-37 expression is an important factor in oral homeostasis that maintains the physiological microbiota but is also involved in the development of oral dysbiosis, infectious diseases (including viral, bacterial, and fungal infections), autoimmune diseases, and oral carcinomas. This peptide has also been proposed as a marker of inflammation severity and treatment outcome. MDPI 2022-05-07 /pmc/articles/PMC9138798/ /pubmed/35625823 http://dx.doi.org/10.3390/biomedicines10051086 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tokajuk, Joanna
Deptuła, Piotr
Piktel, Ewelina
Daniluk, Tamara
Chmielewska, Sylwia
Wollny, Tomasz
Wolak, Przemysław
Fiedoruk, Krzysztof
Bucki, Robert
Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
title Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
title_full Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
title_fullStr Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
title_full_unstemmed Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
title_short Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
title_sort cathelicidin ll-37 in health and diseases of the oral cavity
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138798/
https://www.ncbi.nlm.nih.gov/pubmed/35625823
http://dx.doi.org/10.3390/biomedicines10051086
work_keys_str_mv AT tokajukjoanna cathelicidinll37inhealthanddiseasesoftheoralcavity
AT deptułapiotr cathelicidinll37inhealthanddiseasesoftheoralcavity
AT piktelewelina cathelicidinll37inhealthanddiseasesoftheoralcavity
AT daniluktamara cathelicidinll37inhealthanddiseasesoftheoralcavity
AT chmielewskasylwia cathelicidinll37inhealthanddiseasesoftheoralcavity
AT wollnytomasz cathelicidinll37inhealthanddiseasesoftheoralcavity
AT wolakprzemysław cathelicidinll37inhealthanddiseasesoftheoralcavity
AT fiedorukkrzysztof cathelicidinll37inhealthanddiseasesoftheoralcavity
AT buckirobert cathelicidinll37inhealthanddiseasesoftheoralcavity